Efficacy and safety of transcutaneous electrical nerve stimulation combined with clean intermittent catheterization for neurogenic bladder dysfunction in patients with cauda equina syndrome
- PMID: 40252204
- DOI: 10.1007/s11255-025-04515-0
Efficacy and safety of transcutaneous electrical nerve stimulation combined with clean intermittent catheterization for neurogenic bladder dysfunction in patients with cauda equina syndrome
Abstract
Purpose: Cauda equina syndrome (CES) due to lumbar disk herniation often leads to bladder dysfunction, severely affecting patients' quality of life. This study aims to evaluate the effectiveness of percutaneous electrical stimulation (TENS) combined with clean intermittent catheterization (CIC) for improving bladder function in CES patients.
Methods: A total of 40 patients with bladder dysfunction caused by CES who underwent posterior lumbar spinal fusion from January 2020 to December 2022 were included. Based on the method of catheterization, patients were divided into the CIC or indwelling catheterization (IC) group. Both groups received TENS treatment twice a week for 8 weeks. Urodynamic parameters and quality of life (I-QOL) were assessed before and after treatment.
Results: Significant improvements were observed in the CIC group, with reductions in daily urination frequency (DUF, p < 0.05), increases in daily average single urine volume (DASUV, p < 0.05), and improved urodynamic parameters (MBC, p = 0.031; DP, p < 0.001) compared to the IC group. The CIC group also showed a lower incidence of urinary tract infections. Quality of life significantly improved in both groups, with the CIC group showing a greater improvement (p = 0.036).
Conclusions: TENS combined with CIC significantly improves bladder function and quality of life in CES patients, with a lower risk of urinary tract infections compared to indwelling catheterization.
Keywords: Cauda equina syndrome; Clean intermittent catheterization; Neurogenic bladder dysfunction; Transcutaneous electrical nerve stimulation.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical Approval: This study was approved by the Ethics Committee of Putian First Hospital (No.PTFH2023-024). And informed consent was obtained from all subjects involved in the study. Consent for publication: Consent for publication was obtained from the subjects. No identifying information is used in this manuscript.
Similar articles
-
Reasons for cessation of clean intermittent catheterization after spinal cord injury: Results from the Neurogenic Bladder Research Group spinal cord injury registry.Neurourol Urodyn. 2020 Jan;39(1):211-219. doi: 10.1002/nau.24172. Epub 2019 Oct 2. Neurourol Urodyn. 2020. PMID: 31578784
-
Predictors of low urinary quality of life in spinal cord injury patients on clean intermittent catheterization.Neurourol Urodyn. 2019 Jun;38(5):1332-1338. doi: 10.1002/nau.23983. Epub 2019 Mar 25. Neurourol Urodyn. 2019. PMID: 30912199
-
Value of sufficient clean intermittent catheterization in urinary tract infection and upper urinary tract protection in children with neurogenic bladder.J Pediatr Urol. 2022 Aug;18(4):499.e1-499.e6. doi: 10.1016/j.jpurol.2022.04.011. Epub 2022 Apr 25. J Pediatr Urol. 2022. PMID: 35527206
-
Neurogenic bladder pathophysiology, assessment and management after lumbar diseases.EFORT Open Rev. 2025 Mar 3;10(3):156-165. doi: 10.1530/EOR-24-0087. Print 2025 Mar 1. EFORT Open Rev. 2025. PMID: 40071973 Free PMC article. Review.
-
Quality of life aspects of intermittent catheterization in neurogenic and non-neurogenic patients: a systematic review on heterogeneity in the measurements used.Ther Adv Urol. 2024 Dec 23;16:17562872241303447. doi: 10.1177/17562872241303447. eCollection 2024 Jan-Dec. Ther Adv Urol. 2024. PMID: 39717565 Free PMC article. Review.
References
-
- Kuris EO, McDonald CL, Palumbo MA, Daniels AH (2021) Evaluation and management of cauda equina syndrome. Am J Med 134:1483–1489. https://doi.org/10.1016/j.amjmed.2021.07.021 - DOI - PubMed
-
- Greenhalgh S, Finucane L, Mercer C, Selfe J (2018) Assessment and management of cauda equina syndrome. Musculoskelet Sci Pract 37:69–74. https://doi.org/10.1016/j.msksp.2018.06.002 - DOI - PubMed
-
- Kanematsu R, Hanakita J, Takahashi T et al (2021) Improvement in neurogenic bowel and bladder dysfunction following posterior decompression surgery for cauda equina syndrome: a prospective cohort study. Neurospine. 18:847–853. https://doi.org/10.14245/ns.2142252.126 - DOI - PubMed - PMC
-
- Srikandarajah N, Boissaud-Cooke MA, Clark S, Wilby MJ (2015) Does early surgical decompression in cauda equina syndrome improve bladder outcome? Spine 40:580–583. https://doi.org/10.1097/BRS.0000000000000813 - DOI - PubMed
-
- Wade DT, Cooper J, Peckham N, Belci M (2020) Immunotherapy to reduce frequency of urinary tract infections in people with neurogenic bladder dysfunction; a pilot randomised, placebo-controlled trial. Clin Rehabil 34:1458–1464. https://doi.org/10.1177/0269215520946065 - DOI - PubMed - PMC
LinkOut - more resources
Full Text Sources
Miscellaneous